Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0017638 (
glioma
)
30,880
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Glioma
is the common histological subtype of malignancy in central nervous system, with a high morbidity and mortality. Cancer stem cells (CSCs) play an important role in regulating the tumorigenesis and progression of
glioma
; however, the prognostic biomarkers and therapeutic targets associated with CSC characteristics have not been fully acknowledged in
glioma
. In order to identify the prognostic stemness-related genes (SRGs) of
glioma
in silico, the RNA sequencing data of patients with
glioma
were retrieved from The Cancer Genome Atlas (TCGA) databases. The mRNA expression-based stemness index (mRNAsi) was significantly associated with the
glioma
histologic grade, isocitrate dehydrogenase 1 (IDH1) mutation and overall survival of
glioma
patients by the nonparametric test and Kaplan-Meier survival analysis. A total of 340 SRGs were identified as the overlapped stemness-related differential expressed genes (DEGs) of different histologic grade screened by the univariate Cox analysis. Based on 11 prognostic SRGs, the predict nomogram was constructed with the AUC of 0.832. Moreover, the risk score of the nomogram was an independent prognostic factor, indicating its significant applicability. Besides other eight reported biomarkers of
glioma
, we found that
F2RL2
, CLCNKA and LOXL4 were first identified as prognostic biomarkers for
glioma
. In conclusion, this bioinformatics study demonstrates the mRNAsi as a reliable index for the IDH1 mutation, histologic grade and OS of
glioma
patients and provides a well-applied model for predicting the OS for patients with
glioma
based on prognostic SRGs. Additionally, this in silico study also identifies three novel prognostic biomarkers (
F2RL2
, CLCNKA and LOXL4) for
glioma
patients.
...
PMID:In silico identification of the prognostic biomarkers and therapeutic targets associated with cancer stem cell characteristics of glioma. 3272 65